Superficial siderosis of the central nervous system caused by myxopapillary ependymoma of cauda equine: a case report.

Neurol Sci

Department of Spine, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, No.106, Zhongshan 2nd Road, Guangzhou, 510080, Guangdong, China.

Published: March 2024

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10072-023-07099-8DOI Listing

Publication Analysis

Top Keywords

superficial siderosis
4
siderosis central
4
central nervous
4
nervous system
4
system caused
4
caused myxopapillary
4
myxopapillary ependymoma
4
ependymoma cauda
4
cauda equine
4
equine case
4

Similar Publications

Background: The majority of patients with spontaneous intracranial hypotension (SIH) are symptomatic. Some patients are discovered incidentally. The proportion of asymptomatic SIH has never been defined.

View Article and Find Full Text PDF

Insights into the transcriptomic heterogeneity of brain endothelial cells in normal aging and Alzheimer's disease.

Neural Regen Res

December 2024

State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macao Special Administrative Region, China.

Drug development for Alzheimer's disease Is extremely challenging, as demonstrated by the repeated failures of amyloid-β-targeted therapeutics and the controversies surrounding the amyloid-β cascade hypothesis. More recently, advances in the development of Lecanemab, an anti-amyloid-β monoclonal antibody, have shown positive results in reducing brain A burden and slowing cognitive decline in patients with early- stage Alzheimer's disease in the Phase III clinical trial (Clarity Alzheimer's disease). Despite these promising results, side effects such as amyloid-related imaging abnormalities (ARIA) may limit its usage.

View Article and Find Full Text PDF

Cognitive impairment represents a core and prodromal clinical feature of cerebral amyloid angiopathy (CAA). We sought to assess specific cognitive domains which are mainly affected among patients with CAA and to investigate probable associations with neuroimaging markers and Cerebrospinal Fluid (CSF) biomarkers. Thirty-five patients fulfilling the Boston Criteria v1.

View Article and Find Full Text PDF
Article Synopsis
  • Mild cerebral small vessel disease (CSVD) markers are common but only high CSVD burden increases stroke and dementia risk, potentially identified using a multi-marker CSVD score.
  • In a study of 1,154 participants aged 55 and older, those with three or more CSVD markers had a significantly higher stroke risk during an 8.6-year follow-up.
  • The findings suggest that assessing CSVD burden could enhance stroke risk identification, complementing traditional risk assessments like the Framingham Stroke Risk Profile.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!